# An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly

> **NCT01995734** · — · APPROVED_FOR_MARKETING · sponsor: **Novartis Pharmaceuticals**

## Conditions studied

- Acromegaly

## Interventions

- **DRUG:** Pasireotide long acting release formulation

## Key facts

- **NCT ID:** NCT01995734
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** APPROVED_FOR_MARKETING
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2015-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01995734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01995734, "An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01995734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*